| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 21st, 2005 | 27 | Yes |
Popular Name: JNJ-7706621 JNJ-7706621
Find On: PubMed — Wikipedia — Google
CAS Numbers: 443797-96-4 , [443797-96-4]
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.97 | 5.91 | -18.67 | 5 | 9 | 0 | 146 | 394.363 | 4 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Target | CDK, Aurora Kinase | Selleck Chemicals |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAK1-1-E | Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 200 | 0.35 | Binding ≤ 10μM |
| AAPK1-1-E | AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
| AAPK2-1-E | AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
| ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 820 | 0.32 | Binding ≤ 10μM |
| ACVL1-1-E | Serine/threonine-protein Kinase Receptor R3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.29 | Binding ≤ 10μM |
| ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5900 | 0.27 | Binding ≤ 10μM |
| ADCK3-1-E | Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| ALK-1-E | ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.27 | Binding ≤ 10μM |
| ANKK1-1-E | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 500 | 0.33 | Binding ≤ 10μM |
| AURKA-3-E | Serine/threonine-protein Kinase Aurora-A (cluster #3 Of 3), Eukaryotic | Eukaryotes | 250 | 0.34 | Binding ≤ 10μM |
| AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 160 | 0.35 | Binding ≤ 10μM |
| AURKC-1-E | Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic | Eukaryotes | 86 | 0.37 | Binding ≤ 10μM |
| AVR2A-1-E | Activin Receptor Type-2A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.29 | Binding ≤ 10μM |
| AVR2B-1-E | Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5900 | 0.27 | Binding ≤ 10μM |
| BMP2K-1-E | BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
| BMPR2-1-E | Bone Morphogenetic Protein Receptor Type-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 880 | 0.31 | Binding ≤ 10μM |
| BMX-1-E | Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4700 | 0.28 | Binding ≤ 10μM |
| BRSK1-1-E | BR Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6500 | 0.27 | Binding ≤ 10μM |
| BRSK2-1-E | BR Serine/threonine-protein Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2700 | 0.29 | Binding ≤ 10μM |
| CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.45 | Binding ≤ 10μM |
| CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2 | 0.45 | Binding ≤ 10μM |
| CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
| CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
| CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
| CD11A-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.36 | Binding ≤ 10μM |
| CD11B-1-E | PITSLRE Serine/threonine-protein Kinase CDC2L1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 150 | 0.35 | Binding ≤ 10μM |
| CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 6 | 0.43 | Binding ≤ 10μM |
| CDK14-1-E | Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3600 | 0.28 | Binding ≤ 10μM |
| CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 23 | 0.40 | Binding ≤ 10μM |
| CDK17-1-E | Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 290 | 0.34 | Binding ≤ 10μM |
| CDK18-1-E | Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
| CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 23 | 0.40 | Binding ≤ 10μM |
| CDK3-1-E | Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
| CDK5-1-E | Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 240 | 0.34 | Binding ≤ 10μM |
| CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 760 | 0.32 | Binding ≤ 10μM |
| CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 470 | 0.33 | Binding ≤ 10μM |
| CLK1-1-E | Dual Specificty Protein Kinase CLK1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 660 | 0.32 | Binding ≤ 10μM |
| CLK2-1-E | Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 290 | 0.34 | Binding ≤ 10μM |
| CLK3-1-E | Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 310 | 0.34 | Binding ≤ 10μM |
| CLK4-1-E | Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
| CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4200 | 0.28 | Binding ≤ 10μM |
| CSK22-1-E | Casein Kinase II Alpha (prime) (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.30 | Binding ≤ 10μM |
| DAPK3-1-E | Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5200 | 0.27 | Binding ≤ 10μM |
| DCLK1-1-E | Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.29 | Binding ≤ 10μM |
| DCLK2-1-E | Serine/threonine-protein Kinase DCLK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.28 | Binding ≤ 10μM |
| DCLK3-1-E | Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6500 | 0.27 | Binding ≤ 10μM |
| DMPK-1-E | Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6300 | 0.27 | Binding ≤ 10μM |
| E2AK4-1-E | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3900 | 0.28 | Binding ≤ 10μM |
| EPHA7-1-E | Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
| FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 810 | 0.32 | Binding ≤ 10μM |
| FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 680 | 0.32 | Binding ≤ 10μM |
| FGFR3-1-E | Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 690 | 0.32 | Binding ≤ 10μM |
| FGR-1-E | Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.30 | Binding ≤ 10μM |
| FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 850 | 0.31 | Binding ≤ 10μM |
| GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2400 | 0.29 | Binding ≤ 10μM |
| GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 41 | 0.38 | Binding ≤ 10μM |
| GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 950 | 0.31 | Binding ≤ 10μM |
| IKKE-1-E | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8300 | 0.26 | Binding ≤ 10μM |
| IRAK3-1-E | Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3400 | 0.28 | Binding ≤ 10μM |
| JAK1-1-E | Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 21 | 0.40 | Binding ≤ 10μM |
| JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 220 | 0.35 | Binding ≤ 10μM |
| JAK3-1-E | Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
| KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3600 | 0.28 | Binding ≤ 10μM |
| KC1G1-1-E | Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| KC1G2-1-E | Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 740 | 0.32 | Binding ≤ 10μM |
| KC1G3-1-E | Casein Kinase I Isoform Gamma-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7900 | 0.26 | Binding ≤ 10μM |
| KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 590 | 0.32 | Binding ≤ 10μM |
| KKCC1-1-E | CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.29 | Binding ≤ 10μM |
| KKCC2-1-E | CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2600 | 0.29 | Binding ≤ 10μM |
| KPCD-1-E | Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 4500 | 0.28 | Binding ≤ 10μM |
| KPCD1-1-E | Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 8400 | 0.26 | Binding ≤ 10μM |
| KPCD3-1-E | Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4200 | 0.28 | Binding ≤ 10μM |
| KPCT-1-E | Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4400 | 0.28 | Binding ≤ 10μM |
| KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.28 | Binding ≤ 10μM |
| KS6A2-1-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 410 | 0.33 | Binding ≤ 10μM |
| KS6A4-1-E | Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.29 | Binding ≤ 10μM |
| KSYK-1-E | Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1300 | 0.31 | Binding ≤ 10μM |
| LIMK1-1-E | LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.32 | Binding ≤ 10μM |
| LIMK2-1-E | LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
| M3K9-1-E | Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3600 | 0.28 | Binding ≤ 10μM |
| M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.36 | Binding ≤ 10μM |
| M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 820 | 0.32 | Binding ≤ 10μM |
| M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
| MARK1-1-E | Serine/threonine-protein Kinase MARK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.32 | Binding ≤ 10μM |
| MARK2-1-E | MAP/microtubule Affinity-regulating Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| MARK3-1-E | Serine/threonine-protein Kinase C-TAK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 600 | 0.32 | Binding ≤ 10μM |
| MARK4-1-E | MAP/microtubule Affinity-regulating Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 660 | 0.32 | Binding ≤ 10μM |
| MERTK-1-E | Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.29 | Binding ≤ 10μM |
| MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 650 | 0.32 | Binding ≤ 10μM |
| MK04-1-E | Mitogen-activated Protein Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.30 | Binding ≤ 10μM |
| MK06-1-E | Mitogen-activated Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 480 | 0.33 | Binding ≤ 10μM |
| MK07-1-E | Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 520 | 0.33 | Binding ≤ 10μM |
| MK08-1-E | Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
| MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1300 | 0.31 | Binding ≤ 10μM |
| MK15-1-E | Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
| MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
| MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5600 | 0.27 | Binding ≤ 10μM |
| MP2K3-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1500 | 0.30 | Binding ≤ 10μM |
| MP2K4-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 630 | 0.32 | Binding ≤ 10μM |
| MP2K6-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
| MST4-1-E | Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.35 | Binding ≤ 10μM |
| MYLK-1-E | Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
| NUAK1-1-E | NUAK Family SNF1-like Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
| NUAK2-1-E | NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 26 | 0.39 | Binding ≤ 10μM |
| PAK3-1-E | Serine/threonine-protein Kinase PAK 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
| PAK4-1-E | Serine/threonine-protein Kinase PAK 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2300 | 0.29 | Binding ≤ 10μM |
| PAK6-1-E | Serine/threonine-protein Kinase PAK6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.30 | Binding ≤ 10μM |
| PAK7-1-E | Serine/threonine-protein Kinase PAK7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 830 | 0.32 | Binding ≤ 10μM |
| PDPK1-1-E | 3-phosphoinositide Dependent Protein Kinase-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
| PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4000 | 0.28 | Binding ≤ 10μM |
| PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 910 | 0.31 | Binding ≤ 10μM |
| PI42B-1-E | Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.31 | Binding ≤ 10μM |
| PI51A-1-E | Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9200 | 0.26 | Binding ≤ 10μM |
| PKN2-1-E | Protein Kinase N2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.30 | Binding ≤ 10μM |
| PLK1-1-E | Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.27 | Binding ≤ 10μM |
| PLK3-1-E | Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.27 | Binding ≤ 10μM |
| PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.36 | Binding ≤ 10μM |
| RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4200 | 0.28 | Binding ≤ 10μM |
| RIOK1-1-E | Serine/threonine-protein Kinase RIO1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
| RIOK3-1-E | Serine/threonine-protein Kinase RIO3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| RIPK1-1-E | Receptor-interacting Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
| SIK1-1-E | Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.29 | Binding ≤ 10μM |
| SIK2-1-E | Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.30 | Binding ≤ 10μM |
| SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 48 | 0.38 | Binding ≤ 10μM |
| SRPK1-1-E | Serine/threonine-protein Kinase SRPK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.29 | Binding ≤ 10μM |
| ST17A-1-E | Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5600 | 0.27 | Binding ≤ 10μM |
| STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.36 | Binding ≤ 10μM |
| STK16-1-E | Serine/threonine-protein Kinase 16 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 140 | 0.36 | Binding ≤ 10μM |
| STK24-1-E | Serine/threonine-protein Kinase 24 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.35 | Binding ≤ 10μM |
| STK25-1-E | Serine/threonine-protein Kinase 25 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 360 | 0.33 | Binding ≤ 10μM |
| STK3-1-E | Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 61 | 0.37 | Binding ≤ 10μM |
| STK4-1-E | Serine/threonine-protein Kinase MST1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 130 | 0.36 | Binding ≤ 10μM |
| TEC-1-E | Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
| TESK1-1-E | Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
| TIE1-1-E | Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 260 | 0.34 | Binding ≤ 10μM |
| TIE2-1-E | Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 950 | 0.31 | Binding ≤ 10μM |
| TLK1-1-E | Serine/threonine-protein Kinase Tousled-like 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
| TLK2-1-E | Serine/threonine-protein Kinase Tousled-like 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 750 | 0.32 | Binding ≤ 10μM |
| TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.30 | Binding ≤ 10μM |
| TTK-1-E | Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 190 | 0.35 | Binding ≤ 10μM |
| TYK2-1-E | Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 32 | 0.39 | Binding ≤ 10μM |
| UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.29 | Binding ≤ 10μM |
| VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
| VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.28 | Binding ≤ 10μM |
| VGFR3-1-E | Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1100 | 0.31 | Binding ≤ 10μM |
| Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 110 | 0.36 | Binding ≤ 10μM |
| Z80018-2-O | A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other | Other | 450 | 0.33 | Functional ≤ 10μM |
| Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 120 | 0.36 | Functional ≤ 10μM |
| Z80493-1-O | SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other | Other | 750 | 0.32 | Functional ≤ 10μM |
| Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 254 | 0.34 | Functional ≤ 10μM |
| Z81247-1-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other | Other | 284 | 0.34 | Functional ≤ 10μM |
| Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 590 | 0.32 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 200 | 0.35 | Binding ≤ 1μM |
| ANKK1_HUMAN | Q8NFD2 | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1, Human | 500 | 0.33 | Binding ≤ 1μM |
| BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 180 | 0.35 | Binding ≤ 1μM |
| BMPR2_HUMAN | Q13873 | Bone Morphogenetic Protein Receptor Type-2, Human | 880 | 0.31 | Binding ≤ 1μM |
| KC1G2_HUMAN | P78368 | Casein Kinase I Gamma 2, Human | 740 | 0.32 | Binding ≤ 1μM |
| CCNA1_HUMAN | P78396 | Cyclin A1, Human | 2 | 0.45 | Binding ≤ 1μM |
| CCNA2_HUMAN | P20248 | Cyclin A2, Human | 2 | 0.45 | Binding ≤ 1μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 6 | 0.43 | Binding ≤ 1μM |
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 2 | 0.45 | Binding ≤ 1μM |
| CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 180 | 0.35 | Binding ≤ 1μM |
| Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 110 | 0.36 | Binding ≤ 1μM |
| CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 240 | 0.34 | Binding ≤ 1μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 760 | 0.32 | Binding ≤ 1μM |
| CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 470 | 0.33 | Binding ≤ 1μM |
| MP2K4_HUMAN | P45985 | Dual Specificity Mitogen-activated Protein Kinase Kinase 4, Human | 630 | 0.32 | Binding ≤ 1μM |
| MP2K6_HUMAN | P52564 | Dual Specificity Mitogen-activated Protein Kinase Kinase 6, Human | 1000 | 0.31 | Binding ≤ 1μM |
| CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 290 | 0.34 | Binding ≤ 1μM |
| CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 310 | 0.34 | Binding ≤ 1μM |
| TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 190 | 0.35 | Binding ≤ 1μM |
| CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 660 | 0.32 | Binding ≤ 1μM |
| FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 810 | 0.32 | Binding ≤ 1μM |
| FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 220 | 0.35 | Binding ≤ 1μM |
| FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 510 | 0.33 | Binding ≤ 1μM |
| CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 6 | 0.43 | Binding ≤ 1μM |
| CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 6 | 0.43 | Binding ≤ 1μM |
| CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 6 | 0.43 | Binding ≤ 1μM |
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 160 | 0.35 | Binding ≤ 1μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 41 | 0.38 | Binding ≤ 1μM |
| MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 650 | 0.32 | Binding ≤ 1μM |
| LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 620 | 0.32 | Binding ≤ 1μM |
| LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 1000 | 0.31 | Binding ≤ 1μM |
| MARK4_HUMAN | Q96L34 | MAP/microtubule Affinity-regulating Kinase 4, Human | 660 | 0.32 | Binding ≤ 1μM |
| MK06_HUMAN | Q16659 | Mitogen-activated Protein Kinase 6, Human | 480 | 0.33 | Binding ≤ 1μM |
| MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 520 | 0.33 | Binding ≤ 1μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 120 | 0.36 | Binding ≤ 1μM |
| M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 820 | 0.32 | Binding ≤ 1μM |
| NUAK1_HUMAN | O60285 | NUAK Family SNF1-like Kinase 1, Human | 180 | 0.35 | Binding ≤ 1μM |
| NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 26 | 0.39 | Binding ≤ 1μM |
| CD11B_HUMAN | P21127 | PITSLRE Serine/threonine-protein Kinase CDC2L1, Human | 150 | 0.35 | Binding ≤ 1μM |
| CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 110 | 0.36 | Binding ≤ 1μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 910 | 0.31 | Binding ≤ 1μM |
| KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 410 | 0.33 | Binding ≤ 1μM |
| STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 110 | 0.36 | Binding ≤ 1μM |
| STK16_HUMAN | O75716 | Serine/threonine-protein Kinase 16, Human | 140 | 0.36 | Binding ≤ 1μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 48 | 0.38 | Binding ≤ 1μM |
| STK24_HUMAN | Q9Y6E0 | Serine/threonine-protein Kinase 24, Human | 180 | 0.35 | Binding ≤ 1μM |
| STK25_HUMAN | O00506 | Serine/threonine-protein Kinase 25, Human | 360 | 0.33 | Binding ≤ 1μM |
| AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 250 | 0.34 | Binding ≤ 1μM |
| AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 160 | 0.35 | Binding ≤ 1μM |
| AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 86 | 0.37 | Binding ≤ 1μM |
| MARK3_HUMAN | P27448 | Serine/threonine-protein Kinase C-TAK1, Human | 600 | 0.32 | Binding ≤ 1μM |
| MARK1_HUMAN | Q9P0L2 | Serine/threonine-protein Kinase MARK1, Human | 620 | 0.32 | Binding ≤ 1μM |
| STK4_HUMAN | Q13043 | Serine/threonine-protein Kinase MST1, Human | 130 | 0.36 | Binding ≤ 1μM |
| STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 61 | 0.37 | Binding ≤ 1μM |
| MST4_HUMAN | Q9P289 | Serine/threonine-protein Kinase MST4, Human | 210 | 0.35 | Binding ≤ 1μM |
| PAK7_HUMAN | Q9P286 | Serine/threonine-protein Kinase PAK7, Human | 830 | 0.32 | Binding ≤ 1μM |
| CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 23 | 0.40 | Binding ≤ 1μM |
| CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 290 | 0.34 | Binding ≤ 1μM |
| PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 120 | 0.36 | Binding ≤ 1μM |
| TLK2_HUMAN | Q86UE8 | Serine/threonine-protein Kinase Tousled-like 2, Human | 750 | 0.32 | Binding ≤ 1μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 590 | 0.32 | Binding ≤ 1μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 68 | 0.37 | Binding ≤ 1μM |
| JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 21 | 0.40 | Binding ≤ 1μM |
| JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 220 | 0.35 | Binding ≤ 1μM |
| JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 180 | 0.35 | Binding ≤ 1μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 590 | 0.32 | Binding ≤ 1μM |
| RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 1000 | 0.31 | Binding ≤ 1μM |
| TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 260 | 0.34 | Binding ≤ 1μM |
| TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 1000 | 0.31 | Binding ≤ 1μM |
| TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 950 | 0.31 | Binding ≤ 1μM |
| TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 32 | 0.39 | Binding ≤ 1μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 130 | 0.36 | Binding ≤ 1μM |
| VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 130 | 0.36 | Binding ≤ 1μM |
| PDPK1_HUMAN | O15530 | 3-phosphoinositide Dependent Protein Kinase-1, Human | 3100 | 0.29 | Binding ≤ 10μM |
| ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 5900 | 0.27 | Binding ≤ 10μM |
| AVR2A_HUMAN | P27037 | Activin Receptor Type-2A, Human | 2900 | 0.29 | Binding ≤ 10μM |
| AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 5900 | 0.27 | Binding ≤ 10μM |
| AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 200 | 0.35 | Binding ≤ 10μM |
| ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 7100 | 0.27 | Binding ≤ 10μM |
| AAPK1_HUMAN | Q13131 | AMP-activated Protein Kinase, Alpha-1 Subunit, Human | 1700 | 0.30 | Binding ≤ 10μM |
| AAPK2_HUMAN | P54646 | AMP-activated Protein Kinase, Alpha-2 Subunit, Human | 1800 | 0.30 | Binding ≤ 10μM |
| ANKK1_HUMAN | Q8NFD2 | Ankyrin Repeat And Protein Kinase Domain-containing Protein 1, Human | 500 | 0.33 | Binding ≤ 10μM |
| BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 180 | 0.35 | Binding ≤ 10μM |
| BMPR2_HUMAN | Q13873 | Bone Morphogenetic Protein Receptor Type-2, Human | 880 | 0.31 | Binding ≤ 10μM |
| BRSK1_HUMAN | Q8TDC3 | BR Serine/threonine-protein Kinase 1, Human | 6500 | 0.27 | Binding ≤ 10μM |
| BRSK2_HUMAN | Q8IWQ3 | BR Serine/threonine-protein Kinase 2, Human | 2700 | 0.29 | Binding ≤ 10μM |
| MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 1700 | 0.30 | Binding ≤ 10μM |
| MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 1300 | 0.31 | Binding ≤ 10μM |
| KKCC1_HUMAN | Q8N5S9 | CaM-kinase Kinase Alpha, Human | 2900 | 0.29 | Binding ≤ 10μM |
| KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 2600 | 0.29 | Binding ≤ 10μM |
| KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 3600 | 0.28 | Binding ≤ 10μM |
| KC1G1_HUMAN | Q9HCP0 | Casein Kinase I Gamma 1, Human | 1200 | 0.31 | Binding ≤ 10μM |
| KC1G2_HUMAN | P78368 | Casein Kinase I Gamma 2, Human | 740 | 0.32 | Binding ≤ 10μM |
| KC1G3_HUMAN | Q9Y6M4 | Casein Kinase I Isoform Gamma-3, Human | 7900 | 0.26 | Binding ≤ 10μM |
| CSK22_HUMAN | P19784 | Casein Kinase II Alpha (prime), Human | 2000 | 0.30 | Binding ≤ 10μM |
| ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 1200 | 0.31 | Binding ≤ 10μM |
| CCNA1_HUMAN | P78396 | Cyclin A1, Human | 2 | 0.45 | Binding ≤ 10μM |
| CCNA2_HUMAN | P20248 | Cyclin A2, Human | 2 | 0.45 | Binding ≤ 10μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 6 | 0.43 | Binding ≤ 10μM |
| CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 2 | 0.45 | Binding ≤ 10μM |
| CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 180 | 0.35 | Binding ≤ 10μM |
| Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 110 | 0.36 | Binding ≤ 10μM |
| CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 240 | 0.34 | Binding ≤ 10μM |
| CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 760 | 0.32 | Binding ≤ 10μM |
| CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 470 | 0.33 | Binding ≤ 10μM |
| DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 5200 | 0.27 | Binding ≤ 10μM |
| MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1800 | 0.30 | Binding ≤ 10μM |
| MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 5600 | 0.27 | Binding ≤ 10μM |
| MP2K3_HUMAN | P46734 | Dual Specificity Mitogen-activated Protein Kinase Kinase 3, Human | 1500 | 0.30 | Binding ≤ 10μM |
| MP2K4_HUMAN | P45985 | Dual Specificity Mitogen-activated Protein Kinase Kinase 4, Human | 630 | 0.32 | Binding ≤ 10μM |
| MP2K6_HUMAN | P52564 | Dual Specificity Mitogen-activated Protein Kinase Kinase 6, Human | 1000 | 0.31 | Binding ≤ 10μM |
| CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 290 | 0.34 | Binding ≤ 10μM |
| CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 310 | 0.34 | Binding ≤ 10μM |
| CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 1700 | 0.30 | Binding ≤ 10μM |
| TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 190 | 0.35 | Binding ≤ 10μM |
| TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 3100 | 0.29 | Binding ≤ 10μM |
| CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 660 | 0.32 | Binding ≤ 10μM |
| EPHA7_HUMAN | Q15375 | Ephrin Type-A Receptor 7, Human | 3100 | 0.29 | Binding ≤ 10μM |
| E2AK4_HUMAN | Q9P2K8 | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4, Human | 3900 | 0.28 | Binding ≤ 10μM |
| FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 810 | 0.32 | Binding ≤ 10μM |
| FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 220 | 0.35 | Binding ≤ 10μM |
| FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 510 | 0.33 | Binding ≤ 10μM |
| CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 6 | 0.43 | Binding ≤ 10μM |
| CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 6 | 0.43 | Binding ≤ 10μM |
| CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 6 | 0.43 | Binding ≤ 10μM |
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 160 | 0.35 | Binding ≤ 10μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 41 | 0.38 | Binding ≤ 10μM |
| MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 650 | 0.32 | Binding ≤ 10μM |
| IKKE_HUMAN | Q14164 | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit, Human | 8300 | 0.26 | Binding ≤ 10μM |
| E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 6300 | 0.27 | Binding ≤ 10μM |
| IRAK3_HUMAN | Q9Y616 | Interleukin-1 Receptor-associated Kinase 3, Human | 3400 | 0.28 | Binding ≤ 10μM |
| LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 620 | 0.32 | Binding ≤ 10μM |
| LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 1000 | 0.31 | Binding ≤ 10μM |
| CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 4200 | 0.28 | Binding ≤ 10μM |
| MARK2_HUMAN | Q7KZI7 | MAP/microtubule Affinity-regulating Kinase 2, Human | 1200 | 0.31 | Binding ≤ 10μM |
| MARK4_HUMAN | Q96L34 | MAP/microtubule Affinity-regulating Kinase 4, Human | 660 | 0.32 | Binding ≤ 10μM |
| MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 1100 | 0.31 | Binding ≤ 10μM |
| MK04_HUMAN | P31152 | Mitogen-activated Protein Kinase 4, Human | 1600 | 0.30 | Binding ≤ 10μM |
| MK06_HUMAN | Q16659 | Mitogen-activated Protein Kinase 6, Human | 480 | 0.33 | Binding ≤ 10μM |
| MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 520 | 0.33 | Binding ≤ 10μM |
| M3K9_HUMAN | P80192 | Mitogen-activated Protein Kinase Kinase Kinase 9, Human | 3600 | 0.28 | Binding ≤ 10μM |
| M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 120 | 0.36 | Binding ≤ 10μM |
| M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 820 | 0.32 | Binding ≤ 10μM |
| M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 2100 | 0.29 | Binding ≤ 10μM |
| MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 2100 | 0.29 | Binding ≤ 10μM |
| DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 1200 | 0.31 | Binding ≤ 10μM |
| NUAK1_HUMAN | O60285 | NUAK Family SNF1-like Kinase 1, Human | 180 | 0.35 | Binding ≤ 10μM |
| NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 26 | 0.39 | Binding ≤ 10μM |
| PI51A_HUMAN | Q99755 | Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha, Human | 9200 | 0.26 | Binding ≤ 10μM |
| PI42B_HUMAN | P78356 | Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta, Human | 1300 | 0.31 | Binding ≤ 10μM |
| CD11B_HUMAN | P21127 | PITSLRE Serine/threonine-protein Kinase CDC2L1, Human | 150 | 0.35 | Binding ≤ 10μM |
| CD11A_HUMAN | Q9UQ88 | PITSLRE Serine/threonine-protein Kinase CDC2L2, Human | 110 | 0.36 | Binding ≤ 10μM |
| PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 4000 | 0.28 | Binding ≤ 10μM |
| PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 910 | 0.31 | Binding ≤ 10μM |
| KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 4500 | 0.28 | Binding ≤ 10μM |
| KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 8400 | 0.26 | Binding ≤ 10μM |
| KPCD3_HUMAN | O94806 | Protein Kinase C Nu, Human | 4200 | 0.28 | Binding ≤ 10μM |
| KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 4400 | 0.28 | Binding ≤ 10μM |
| PKN2_HUMAN | Q16513 | Protein Kinase N2, Human | 1900 | 0.30 | Binding ≤ 10μM |
| MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 2800 | 0.29 | Binding ≤ 10μM |
| RIPK1_HUMAN | Q13546 | Receptor-interacting Serine/threonine-protein Kinase 1, Human | 1800 | 0.30 | Binding ≤ 10μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 4000 | 0.28 | Binding ≤ 10μM |
| KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 410 | 0.33 | Binding ≤ 10μM |
| KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 3000 | 0.29 | Binding ≤ 10μM |
| STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 110 | 0.36 | Binding ≤ 10μM |
| STK16_HUMAN | O75716 | Serine/threonine-protein Kinase 16, Human | 140 | 0.36 | Binding ≤ 10μM |
| ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 5600 | 0.27 | Binding ≤ 10μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 48 | 0.38 | Binding ≤ 10μM |
| STK24_HUMAN | Q9Y6E0 | Serine/threonine-protein Kinase 24, Human | 180 | 0.35 | Binding ≤ 10μM |
| STK25_HUMAN | O00506 | Serine/threonine-protein Kinase 25, Human | 360 | 0.33 | Binding ≤ 10μM |
| AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 250 | 0.34 | Binding ≤ 10μM |
| AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 160 | 0.35 | Binding ≤ 10μM |
| AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 86 | 0.37 | Binding ≤ 10μM |
| MARK3_HUMAN | P27448 | Serine/threonine-protein Kinase C-TAK1, Human | 600 | 0.32 | Binding ≤ 10μM |
| DCLK1_HUMAN | O15075 | Serine/threonine-protein Kinase DCLK1, Human | 2500 | 0.29 | Binding ≤ 10μM |
| DCLK2_HUMAN | Q8N568 | Serine/threonine-protein Kinase DCLK2, Human | 4500 | 0.28 | Binding ≤ 10μM |
| DCLK3_HUMAN | Q9C098 | Serine/threonine-protein Kinase DCLK3, Human | 6500 | 0.27 | Binding ≤ 10μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 2400 | 0.29 | Binding ≤ 10μM |
| MARK1_HUMAN | Q9P0L2 | Serine/threonine-protein Kinase MARK1, Human | 620 | 0.32 | Binding ≤ 10μM |
| STK4_HUMAN | Q13043 | Serine/threonine-protein Kinase MST1, Human | 130 | 0.36 | Binding ≤ 10μM |
| STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 61 | 0.37 | Binding ≤ 10μM |
| MST4_HUMAN | Q9P289 | Serine/threonine-protein Kinase MST4, Human | 210 | 0.35 | Binding ≤ 10μM |
| PAK3_HUMAN | O75914 | Serine/threonine-protein Kinase PAK 3, Human | 2100 | 0.29 | Binding ≤ 10μM |
| PAK4_HUMAN | O96013 | Serine/threonine-protein Kinase PAK 4, Human | 2300 | 0.29 | Binding ≤ 10μM |
| PAK6_HUMAN | Q9NQU5 | Serine/threonine-protein Kinase PAK6, Human | 1400 | 0.30 | Binding ≤ 10μM |
| PAK7_HUMAN | Q9P286 | Serine/threonine-protein Kinase PAK7, Human | 830 | 0.32 | Binding ≤ 10μM |
| CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 23 | 0.40 | Binding ≤ 10μM |
| CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 290 | 0.34 | Binding ≤ 10μM |
| CDK18_HUMAN | Q07002 | Serine/threonine-protein Kinase PCTAIRE-3, Human | 2100 | 0.29 | Binding ≤ 10μM |
| CDK14_HUMAN | O94921 | Serine/threonine-protein Kinase PFTAIRE-1, Human | 3600 | 0.28 | Binding ≤ 10μM |
| PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 5000 | 0.27 | Binding ≤ 10μM |
| PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 7100 | 0.27 | Binding ≤ 10μM |
| PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 120 | 0.36 | Binding ≤ 10μM |
| ACVL1_HUMAN | P37023 | Serine/threonine-protein Kinase Receptor R3, Human | 2900 | 0.29 | Binding ≤ 10μM |
| RIOK1_HUMAN | Q9BRS2 | Serine/threonine-protein Kinase RIO1, Human | 1100 | 0.31 | Binding ≤ 10μM |
| RIOK3_HUMAN | O14730 | Serine/threonine-protein Kinase RIO3, Human | 1200 | 0.31 | Binding ≤ 10μM |
| SIK1_HUMAN | P57059 | Serine/threonine-protein Kinase SIK1, Human | 2200 | 0.29 | Binding ≤ 10μM |
| SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 1600 | 0.30 | Binding ≤ 10μM |
| SRPK1_HUMAN | Q96SB4 | Serine/threonine-protein Kinase SRPK1, Human | 2800 | 0.29 | Binding ≤ 10μM |
| TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 1400 | 0.30 | Binding ≤ 10μM |
| TLK1_HUMAN | Q9UKI8 | Serine/threonine-protein Kinase Tousled-like 1, Human | 1100 | 0.31 | Binding ≤ 10μM |
| TLK2_HUMAN | Q86UE8 | Serine/threonine-protein Kinase Tousled-like 2, Human | 750 | 0.32 | Binding ≤ 10μM |
| KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 1400 | 0.30 | Binding ≤ 10μM |
| ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 1200 | 0.31 | Binding ≤ 10μM |
| BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 4700 | 0.28 | Binding ≤ 10μM |
| FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 2000 | 0.30 | Binding ≤ 10μM |
| JAK1_HUMAN | P23458 | Tyrosine-protein Kinase JAK1, Human | 21 | 0.40 | Binding ≤ 10μM |
| JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 220 | 0.35 | Binding ≤ 10μM |
| JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 180 | 0.35 | Binding ≤ 10μM |
| FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 1400 | 0.30 | Binding ≤ 10μM |
| RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 1000 | 0.31 | Binding ≤ 10μM |
| TIE1_HUMAN | P35590 | Tyrosine-protein Kinase Receptor Tie-1, Human | 260 | 0.34 | Binding ≤ 10μM |
| UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 2200 | 0.29 | Binding ≤ 10μM |
| KSYK_HUMAN | P43405 | Tyrosine-protein Kinase SYK, Human | 1300 | 0.31 | Binding ≤ 10μM |
| TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 1000 | 0.31 | Binding ≤ 10μM |
| TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 950 | 0.31 | Binding ≤ 10μM |
| TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 32 | 0.39 | Binding ≤ 10μM |
| VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 2100 | 0.29 | Binding ≤ 10μM |
| VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 130 | 0.36 | Binding ≤ 10μM |
| VGFR2_MOUSE | P35918 | Vascular Endothelial Growth Factor Receptor 2, Mouse | 130 | 0.36 | Binding ≤ 10μM |
| VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 1100 | 0.31 | Binding ≤ 10μM |
| Z80018 | Z80018 | A-375 (Malignant Melanoma Cells) | 447 | 0.33 | Functional ≤ 10μM |
| Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 250 | 0.34 | Functional ≤ 10μM |
| Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 280 | 0.34 | Functional ≤ 10μM |
| Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 590 | 0.32 | Functional ≤ 10μM |
| Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 120 | 0.36 | Functional ≤ 10μM |
| Z80493 | Z80493 | SK-OV-3 (Ovarian Carcinoma Cells) | 750 | 0.32 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Activated point mutants of FGFR2 | |
| activated TAK1 mediates p38 MAPK activation | |
| Activation of ATR in response to replication stress | |
| Activation of BIM and translocation to mitochondria | |
| Activation of BMF and translocation to mitochondria | |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| Activation of PKB | |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
| Activation of Rac | |
| Activation of the AP-1 family of transcription factors | |
| Activation of the pre-replicative complex | |
| AKT phosphorylates targets in the cytosol | |
| AMPK inhibits chREBP transcriptional activation activity | |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
| APC truncation mutants have impaired AXIN binding | |
| APC/C:Cdc20 mediated degradation of Cyclin B | |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
| Apoptotic cleavage of cellular proteins | |
| Apoptotic execution phase | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| Calmodulin induced events | |
| Caspase-8 activation by cleavage | |
| CD28 dependent PI3K/Akt signaling | |
| CD28 dependent Vav1 pathway | |
| CDK-mediated phosphorylation and removal of Cdc6 | |
| CDO in myogenesis | |
| Cell surface interactions at the vascular wall | |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
| Circadian Clock | |
| Condensation of Prometaphase Chromosomes | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| CREB phosphorylation | |
| CREB phosphorylation through the activation of CaMKK | |
| CREB phosphorylation through the activation of Ras | |
| CRMPs in Sema3A signaling | |
| CTLA4 inhibitory signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin A:Cdk2-associated events at S phase entry | |
| Cyclin B2 mediated events | |
| Cyclin D associated events in G1 | |
| Cyclin E associated events during G1/S transition | |
| DAG and IP3 signaling | |
| DAP12 signaling | |
| DARPP-32 events | |
| Degradation of beta-catenin by the destruction complex | |
| Depolymerisation of the Nuclear Lamina | |
| Dimerization of procaspase-8 | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| DNA Damage/Telomere Stress Induced Senescence | |
| Downstream signal transduction | |
| Downstream TCR signaling | |
| DSCAM interactions | |
| Dual incision reaction in GG-NER | |
| Dual incision reaction in TC-NER | |
| E2F mediated regulation of DNA replication | |
| E2F-enabled inhibition of pre-replication complex formation | |
| Effects of PIP2 hydrolysis | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| Ephrin signaling | |
| ERK/MAPK targets | |
| ERK1 activation | |
| ERK2 activation | |
| ERKs are inactivated | |
| Factors involved in megakaryocyte development and platelet production | |
| Fc epsilon receptor (FCERI) signaling | |
| FCERI mediated Ca+2 mobilization | |
| FCERI mediated MAPK activation | |
| FCERI mediated NF-kB activation | |
| FCGR activation | |
| Formation of HIV elongation complex in the absence of HIV Tat | |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | |
| Formation of incision complex in GG-NER | |
| Formation of RNA Pol II elongation complex | |
| Formation of the Early Elongation Complex | |
| Formation of the HIV-1 Early Elongation Complex | |
| Formation of transcription-coupled NER (TC-NER) repair complex | |
| G alpha (z) signalling events | |
| G beta:gamma signalling through PI3Kgamma | |
| G0 and Early G1 | |
| G1/S-Specific Transcription | |
| G2 Phase | |
| G2/M DNA replication checkpoint | |
| Gastrin-CREB signalling pathway via PKC and MAPK | |
| Generation of second messenger molecules | |
| Golgi Associated Vesicle Biogenesis | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| GPVI-mediated activation cascade | |
| Growth hormone receptor signaling | |
| HIV elongation arrest and recovery | |
| HIV Transcription Initiation | |
| HuR stabilizes mRNA | |
| IKK complex recruitment mediated by RIP1 | |
| Import of palmitoyl-CoA into the mitochondrial matrix | |
| Inactivation, recovery and regulation of the phototransduction cascade | |
| Inhibition of PKR | |
| Integrin alphaIIb beta3 signaling | |
| Integrin cell surface interactions | |
| Interactions of Tat with host cellular proteins | |
| Interferon alpha/beta signaling | |
| Interferon gamma signaling | |
| Interleukin receptor SHC signaling | |
| Interleukin-1 signaling | |
| Interleukin-2 signaling | |
| Interleukin-3, 5 and GM-CSF signaling | |
| Interleukin-6 signaling | |
| Interleukin-7 signaling | |
| ISG15 antiviral mechanism | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MASTL Facilitates Mitotic Progression | |
| Meiotic recombination | |
| MEK activation | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| Mitotic Metaphase/Anaphase Transition | |
| Mitotic Prometaphase | |
| Mitotic Telophase/Cytokinesis | |
| mRNA Capping | |
| MyD88:Mal cascade initiated on plasma membrane | |
| Negative regulators of RIG-I/MDA5 signaling | |
| Netrin-1 signaling | |
| Neurophilin interactions with VEGF and VEGFR | |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | |
| NOD1/2 Signaling Pathway | |
| NoRC negatively regulates rRNA expression | |
| NRAGE signals death through JNK | |
| NRIF signals cell death from the nucleus | |
| Nuclear Pore Complex (NPC) Disassembly | |
| Orc1 removal from chromatin | |
| Oxidative Stress Induced Senescence | |
| p53-Dependent G1 DNA Damage Response | |
| Pausing and recovery of HIV elongation | |
| Pausing and recovery of Tat-mediated HIV elongation | |
| Phosphorylation of Emi1 | |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
| Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
| Phosphorylation of the APC/C | |
| PIP3 activates AKT signaling | |
| Platelet sensitization by LDL | |
| Polo-like kinase mediated events | |
| Prolactin receptor signaling | |
| RAF phosphorylates MEK | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recruitment of NuMA to mitotic centrosomes | |
| Recycling pathway of L1 | |
| Regulation by c-FLIP | |
| Regulation of actin dynamics for phagocytic cup formation | |
| Regulation of AMPK activity via LKB1 | |
| Regulation of APC/C activators between G1/S and early anaphase | |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen | |
| Regulation of HSF1-mediated heat shock response | |
| Regulation of IFNA signaling | |
| Regulation of IFNG signaling | |
| Regulation of KIT signaling | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of Rheb GTPase activity by AMPK | |
| Regulation of signaling by CBL | |
| Regulation of signaling by NODAL | |
| Resolution of Sister Chromatid Cohesion | |
| RIP-mediated NFkB activation via ZBP1 | |
| RMTs methylate histone arginines | |
| RNA Pol II CTD phosphorylation and interaction with CE | |
| RNA Polymerase I Chain Elongation | |
| RNA Polymerase I Promoter Escape | |
| RNA Polymerase I Transcription Initiation | |
| RNA Polymerase I Transcription Termination | |
| RNA Polymerase II HIV Promoter Escape | |
| RNA Polymerase II Pre-transcription Events | |
| RNA Polymerase II Promoter Escape | |
| RNA Polymerase II Transcription Elongation | |
| RNA Polymerase II Transcription Initiation | |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
| Role of Abl in Robo-Slit signaling | |
| Role of DCC in regulating apoptosis | |
| Role of LAT2/NTAL/LAB on calcium mobilization | |
| Role of phospholipids in phagocytosis | |
| RSK activation | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| SCF(Skp2)-mediated degradation of p27/p21 | |
| Sema3A PAK dependent Axon repulsion | |
| Sema4D induced cell migration and growth-cone collapse | |
| Sema4D mediated inhibition of cell attachment and migration | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| Separation of Sister Chromatids | |
| Signal transduction by L1 | |
| Signaling by activated point mutants of FGFR1 | |
| Signaling by activated point mutants of FGFR3 | |
| Signaling by Activin | |
| Signaling by BMP | |
| Signaling by FGFR | |
| Signaling by FGFR mutants | |
| Signaling by FGFR2 amplification mutants | |
| Signaling by FGFR3 mutants | |
| Signaling by Hippo | |
| Signaling by Leptin | |
| Signaling by NODAL | |
| Signaling by PDGF | |
| Signaling by SCF-KIT | |
| Signalling to ERK5 | |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
| Smooth Muscle Contraction | |
| Sphingolipid de novo biosynthesis | |
| Synthesis of PIPs at the plasma membrane | |
| t(4;14) translocations of FGFR3 | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| Tat-mediated elongation of the HIV-1 transcript | |
| Tat-mediated HIV elongation arrest and recovery | |
| Tie2 Signaling | |
| TNF signaling | |
| TRAF3-dependent IRF activation pathway | |
| TRAF6 mediated IRF7 activation | |
| Transcription of the HIV genome | |
| Translocation of GLUT4 to the plasma membrane | |
| TRIF-mediated programmed cell death | |
| TRP channels | |
| truncations of AMER1 destabilize the destruction complex | |
| Uptake and function of anthrax toxins | |
| VEGF binds to VEGFR leading to receptor dimerization | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated cell proliferation | |
| VEGFR2 mediated vascular permeability | |
| WNT mediated activation of DVL | |
| XBP1(S) activates chaperone genes |